TW200607516A - Anti-angiogenic compositions containing beeswax - Google Patents

Anti-angiogenic compositions containing beeswax

Info

Publication number
TW200607516A
TW200607516A TW094124964A TW94124964A TW200607516A TW 200607516 A TW200607516 A TW 200607516A TW 094124964 A TW094124964 A TW 094124964A TW 94124964 A TW94124964 A TW 94124964A TW 200607516 A TW200607516 A TW 200607516A
Authority
TW
Taiwan
Prior art keywords
extract
compositions containing
beeswax
angiogenic compositions
relates
Prior art date
Application number
TW094124964A
Other languages
Chinese (zh)
Other versions
TWI369989B (en
Inventor
Paul Frank Davis
Original Assignee
Univ Otago
Immuno Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Otago, Immuno Res Ltd filed Critical Univ Otago
Publication of TW200607516A publication Critical patent/TW200607516A/en
Application granted granted Critical
Publication of TWI369989B publication Critical patent/TWI369989B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Husbandry (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to compositions comprising synergistically effective amounts of an anti-angiogenic extract and beeswax. The invention relates particularly to compositions containing an extract from shark meat or an extract from mussel meat, optionally including a mushroom extract, together with beeswax. The invention also relates to a method of treating or preventing diseases or disorders where it is desirable to inhibit angiogenesis using a composition of the invention.
TW094124964A 2004-07-22 2005-07-22 Anti-angiogenic compositions containing beeswax TWI369989B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ53426604 2004-07-22

Publications (2)

Publication Number Publication Date
TW200607516A true TW200607516A (en) 2006-03-01
TWI369989B TWI369989B (en) 2012-08-11

Family

ID=35785496

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094124964A TWI369989B (en) 2004-07-22 2005-07-22 Anti-angiogenic compositions containing beeswax

Country Status (5)

Country Link
JP (1) JP2008507511A (en)
KR (1) KR20070047775A (en)
CN (1) CN101027068A (en)
TW (1) TWI369989B (en)
WO (1) WO2006009477A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008303199A (en) * 2007-06-11 2008-12-18 Heimat Ltd Anti-neovascularization composition containing lipid extract of grifola frondosa and genistein
US8279355B2 (en) * 2009-09-25 2012-10-02 Intel Corporation Method and apparatus to support multi-channel reception

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07308169A (en) * 1994-05-16 1995-11-28 Haputo Internatl:Kk Admixture for processed food
TW425285B (en) * 1996-06-10 2001-03-11 Viva America Marketing Inc Fish oil and garlic nutritive supplement
US5955102A (en) * 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants
CN1245991C (en) * 2000-12-20 2006-03-22 工业研究有限公司 Shark meat extract
RO119121B1 (en) * 2002-01-29 2004-04-30 Dana Mihaela Mihele Pharmaceutical preparation containing oil extracted from the shark liver, having antiinflammatory and healing up properties
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
JP4506079B2 (en) * 2002-12-18 2010-07-21 ビーエイチエヌ株式会社 Angiogenesis inhibitor
JP4623999B2 (en) * 2004-05-07 2011-02-02 丸善製薬株式会社 Aldose reductase activity inhibitor, preventive / therapeutic agent for diabetic complications, and food and drink for the prevention / treatment of diabetic complications

Also Published As

Publication number Publication date
CN101027068A (en) 2007-08-29
TWI369989B (en) 2012-08-11
WO2006009477A1 (en) 2006-01-26
JP2008507511A (en) 2008-03-13
KR20070047775A (en) 2007-05-07

Similar Documents

Publication Publication Date Title
WO2007022344A3 (en) Methods and compositions for the preventioin and treatment of kidney disease
WO2006024018A3 (en) Compositions for treating nociceptive pain
ZA200703002B (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
WO2006044505A3 (en) Compounds for nonsense suppression, and methods for their use
UA90668C2 (en) Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
WO2005117846A3 (en) Ice inhibitors for the treatment of autoinflammatory diseases
WO2007121188A3 (en) Compositions and methods of using r(+) pramipexole
SA519410204B1 (en) S1PR4-Targeting Composition for Preventing or Treating Non-Alcoholic Steatohepatitis
HN2006000971A (en) METHODS TO PREPARE COMPOSITIONS OR DOSAGE FORMS THAT INCLUDE A GRP119 AGONIST THAT HAS THE EFFECT OF A GLP-1 SECRETAGOG
WO2007038610A3 (en) Use of natural products for treatment of neurological disorders
WO2005105107A3 (en) Hormone treatment of multiple sclerosis
WO2009125964A3 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
WO2005017190A3 (en) Mitotic kinesin inhibitors
WO2007011759A3 (en) Inhibitors of mitotic kinesin
WO2005018547A3 (en) Mitotic kinesin inhibitors
WO2006009975A3 (en) Histamine to treat disorders affecting muscle function
WO2006078574A3 (en) Mitotic kinesin inhibitors
WO2009009417A3 (en) Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
DE602004016486D1 (en) COMPOSITION FOR INHIBITING OR PREVENTING THE REDUCTION OF BONE DENSITY
WO2005082375A3 (en) Treatment of interstitial cystitis with vitamin d compounds
WO2006053184A3 (en) Methods for treating or preventing a vascular disease
WO2006007538A3 (en) Composition and method for the treatment of asthma symptoms
HK1131340A1 (en) Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance
TW200607516A (en) Anti-angiogenic compositions containing beeswax
WO2004060878A3 (en) Inhibitors of phosphatases

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees